Oramed Pharmaceuticals Inc.
ORMP | NASDAQ
$4.76
+$0.06 (+1.28%)
Sep 22, 2026, 10:54 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Nov 29, 2021 | Q3 2021 Aug 30, 2021 | Q2 2021 May 30, 2021 | Q1 2021 Feb 27, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 2M | 2M | 2M | 2M | n/a | n/a | n/a | 674K | 1.34M | 2.02M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M |
Cost of Revenue | 61K | 61K | 2.02M | 2.05M | 2.02M | 2.02M | 31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -91K | -121K | -78K | -79K | -100K | -124K | -193K | -215K | -163K | 565K | 1.29M | 2.02M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M |
Operating Income | -14.52M | -14.25M | -15.09M | -13.01M | -13.67M | -14.32M | -12.78M | -13.06M | -12.87M | -13.52M | -15.77M | -21.63M | -26.93M | -34.55M | -40.6M | -38.92M | -38.14M | -32.84M | -26.46M | -24.22M | -19.83M | -15.99M |
Interest Income | 883K | 16.15M | 15.88M | -3.45M | -3.96M | -5.09M | n/a | 37.71M | 38.14M | 26.39M | 22.89M | 4.51M | 4.08M | 1.95M | 894K | 1.03M | 1.03M | 681K | 137K | n/a | 121K | 321K |
Pretax Income | 220.28M | 131.82M | 75.32M | 55.74M | -22.22M | -24.51M | -15.92M | 7.16M | 22.38M | 10.23M | 5.09M | -16.94M | -20.81M | -30.57M | -37.66M | -37.03M | -37.06M | -31.62M | -25.52M | -22.99M | -18.8M | -15.46M |
Net Income | 174.87M | 110M | 64.05M | 43.85M | -24.16M | -28.24M | -19.06M | 4.47M | 20.86M | 10.46M | 7.12M | -14.76M | -18.79M | -28.13M | -36.75M | -36.1M | -35.7M | -30.38M | -24.56M | -22.24M | -18.38M | -15.46M |
Selling & General & Admin | 9.79M | 8.48M | 8.72M | 7.17M | 6.74M | 6.98M | 6.46M | 6.43M | 7.52M | 8.47M | 8.14M | 9.17M | 10.76M | 11.03M | 15.66M | 14.84M | 13.57M | 11.95M | 7.53M | 5.94M | 4.42M | 4.15M |
Research & Development | 4.74M | 5.77M | 6.38M | 5.85M | 6.94M | 7.35M | 6.32M | 6.63M | 5.34M | 5.72M | 8.97M | 14.48M | 18.87M | 26.23M | 27.64M | 26.77M | 27.27M | 23.59M | 21.63M | 20.99M | 18.11M | 14.54M |
Other Expenses | -31K | -31K | -31K | -31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 14.49M | 14.22M | 15.07M | 12.99M | 13.69M | 14.33M | 12.78M | 13.06M | 12.87M | 14.2M | 17.11M | 23.65M | 29.63M | 37.26M | 43.3M | 41.61M | 40.84M | 35.54M | 29.16M | 26.93M | 22.53M | 18.69M |
Interest Expense | -337K | -337K | 2.22M | -12.86M | 2.56M | 2.82M | 853K | 17.48M | 2.89M | 2.63M | 2.04M | 826K | 1.04M | 1.39M | 1.93M | 2.11M | 1.07M | 1.21M | 928K | 1.01M | 1.15M | 661K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -663K | -471K | -287K | 131K | 1.26M | 1.45M | 1.85M | 2.02M | 1.56M | 1.18M | 585K | n/a | n/a | n/a |
Cost & Expenses | 14.52M | 14.25M | 17.09M | 15.01M | 15.67M | 16.32M | 12.78M | 13.06M | 12.87M | 14.2M | 17.11M | 23.65M | 29.63M | 37.26M | 43.3M | 41.61M | 40.84M | 35.54M | 29.16M | 26.93M | 22.53M | 18.69M |
Income Tax Expense | 45.41M | 21.85M | 11.31M | 11.94M | 2.01M | 3.77M | 3.18M | 2.77M | 2.01M | 254K | -1.56M | -1.75M | -2.03M | -2.44M | -910K | -925K | -1.36M | -1.24M | -1.22M | -1.27M | -1.07M | -643K |
Shares Outstanding (Basic) | 41.04M | 40.77M | 41.4M | 41.76M | 41.74M | 41.23M | 39.92M | 40.9M | 40.96M | 40.84M | 40.38M | 40.45M | 40.23M | 40.04M | 39M | 39.1M | 38.8M | 38.68M | 36.67M | 29.93M | 29.93M | 27M |
Shares Outstanding (Diluted) | 42.5M | 41.97M | 42.42M | 42.77M | 42.61M | 41.23M | 39.92M | 40.9M | 41.59M | 41.56M | 40.51M | 40.45M | 40.23M | 40.04M | 39M | 39.1M | 38.8M | 38.68M | 36.67M | 29.93M | 29.93M | 27M |
EPS (Basic) | 4.23 | 2.65 | 1.52 | 1.03 | -0.61 | -0.71 | -0.48 | 0.11 | 0.51 | 0.26 | 0.18 | -0.37 | -0.48 | -0.72 | -0.95 | -0.95 | -0.99 | -0.89 | -0.79 | -0.80 | -0.70 | -0.63 |
EPS (Diluted) | 4.11 | 2.58 | 1.48 | 0.99 | -0.62 | -0.71 | -0.48 | 0.11 | 0.51 | 0.26 | 0.18 | -0.37 | -0.48 | -0.72 | -0.95 | -0.95 | -0.99 | -0.89 | -0.79 | -0.80 | -0.70 | -0.63 |
EBITDA | 167.27M | 78.84M | 78M | 58.42M | -4.1M | -6.11M | 546K | 24.86M | 25.49M | 10.6M | 3.25M | -18.1M | -23.87M | -31.54M | -37.61M | -38.73M | -37.95M | -32.63M | -26.23M | -24.15M | -19.9M | -15.88M |
EBIT | 167.18M | 78.72M | 77.88M | 58.3M | -4.24M | -6.27M | 353K | 24.64M | 25.27M | 10.38M | 3.05M | -21.2M | -26.93M | -34.55M | -40.6M | -38.78M | -38M | -32.7M | -26.32M | -24.22M | -16.81M | -10.7M |
Depreciation & Amortization | 91K | 121K | 121K | 122K | 143K | 167K | 193K | 215K | 217K | 215K | 196K | 3.09M | 3.06M | 3.02M | 2.99M | 53K | 57K | 70K | 87K | 77K | 60K | 35K |
Add to Watchlist
Select watchlists to add or remove ORMP